ZIM Laboratories Limited (BOM:541400)
131.80
-5.70 (-4.15%)
At close: Nov 6, 2026
ZIM Laboratories Revenue
ZIM Laboratories had revenue of 1.08B INR in the quarter ending September 30, 2026, with 21.46% growth. This brings the company's total for the last twelve months to 4.13B, up 13.05% year-over-year. In the fiscal year ending March 31, 2026, ZIM Laboratories had annual revenue of 3.74B, down -1.22%. That makes ZIM Laboratories the 28,878th largest company in the world by revenue and 1,947th in India.
Revenue (ttm)
4.13B
Revenue Growth
+13.05%
P/S Ratio
1.71
Revenue / Employee
6.54M
Employees
632
Market Cap
7.07B
Revenue by Geography
- Outside India 3.15B 84.1%
- India 594.43M 15.9%
Fiscal year ended Mar 31, 2026 See the full ZIM Laboratories breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 3.74B | -46.31M | -1.22% |
| Mar 31, 2025 | 3.79B | 115.14M | 3.13% |
| Mar 31, 2024 | 3.68B | -310.92M | -7.80% |
| Mar 31, 2023 | 3.99B | 651.00M | 19.52% |
| Mar 31, 2022 | 3.34B | 261.64M | 8.51% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Kopran | 7.94B |
| Sudarshan Pharma Industries | 7.80B |
| Anuh Pharma | 7.78B |
| Lincoln Pharmaceuticals | 7.22B |
| Wanbury | 6.76B |
| Fermenta Biotech | 5.07B |
| Bharat Parenterals | 3.95B |
| Albert David | 3.64B |
ZIM Laboratories News
- 11 months ago - Why ZIM Laboratories has received CDSCO approval for its new Naproxen + Esomeprazole capsules - Business Upturn
- 1 year ago - ZIM Laboratories secures marketing authorization in Australia for urology drug combination - Business Upturn
- 1 year ago - ZIM Laboratories shares in focus as company gets first marketing approval in Australia - Business Upturn